Accueil>>Signaling Pathways>> Proteases>> Tyrosinases>>Tyrosinase-IN-12

Tyrosinase-IN-12

Catalog No.GC71084

Tyrosinase-IN-12 est un puissant inhibiteur non compétitif de la Tyrosinase avec une IC50 de 49,33 ± 2,64 µm et une ki de 31,25 ± 0,25 µm.

Products are for research use only. Not for human use. We do not sell to patients.

Tyrosinase-IN-12 Chemical Structure

Cas No.: 1860779-42-5

Taille Prix Stock Qté
5 mg
111,00 $US
En stock
10 mg
179,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
Non-competitive tyrosinase inhibitor (Tyrosinase-IN-12) is a potent, non-competitive tyrosinase inhibitor with an IC50 value of 49.33 ± 2.64 µM and Ki value of 31.25 ± 0.25 µM. Non-competitive tyrosinase inhibitor (Tyrosinase-IN-12) have the highest radical scavenging activity to reduce the production of reactive oxygen species (ROS) with an IC50 value of 25.39 ± 0.77 µM. Non-competitive tyrosinase inhibitor (Tyrosinase-IN-12) can be used for anti-browning substances in the food and agricultural sectors.

Non-competitive tyrosinase inhibitor (Tyrosinase-IN-12) (3day) is a potential anti-browning agent for fresh-cut fruits and vegetables[1].

References:
[1]. Djafarou S, et al. Synthesis and evaluation of the antioxidant and anti-tyrosinase activities of thiazolyl hydrazone derivatives and their application in the anti-browning of fresh-cut potato. Food Chem.

Avis

Review for Tyrosinase-IN-12

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tyrosinase-IN-12

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.